CRH-stimulated oxytocin in patients with hypopituitarism and hypothalamic damage: A randomized, single-blind, crossover, placebo-controlled trial

DOI: 10.1530/endoabs.99.rc5.5 Publication Date: 2024-05-08T03:30:51Z